
Cancer drug prices may fall up to 70% from November 9
The story in brief
Cancer drug prices may drop up to 70% starting November 9, as the government mandates revised pricing across the supply chain. The move expands on a 2019 pilot, requiring pharmaceutical companies to publish updated price lists and hospitals to display new rates, aiming to curb excessive margins while ensuring access to essential medicines.